Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma

NCT ID: NCT00598949

Last Updated: 2010-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine genetic links among blood-relatives and between spouses of patients with pituitary tumors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the family study is to investigate the genetic basis for the development of pituitary tumors by assessing the prevalence of pituitary tumors in relatives of probands with the disease as compared to the prevalence in unrelated spouses sharing a similar environment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pituitary Tumor

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pituitary Adenoma Tumor Acromegaly Prolactinoma Cushing's

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients harboring secretory or non-secretory adenomas and/or siblings and/or spouses

Exclusion Criteria

* patient without consenting siblings and/or siblings and/or spouses
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cedars-Sinai Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cedars-Sinai Medical Center, Pituitary Center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vivian Bonert, MD

Role: PRINCIPAL_INVESTIGATOR

Cedars-Sinai Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cedars-Sinai Medical Center, Pituitary Center

Los Angeles, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Billy Gellepis

Role: CONTACT

Phone: 310-423-3395

Email: [email protected]

Lori korsakoff, RN

Role: CONTACT

Phone: 310-423-2411

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vivien Bonert, MD

Role: primary

Lori Korsakoff, RN

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3765

Identifier Type: -

Identifier Source: secondary_id

3765

Identifier Type: -

Identifier Source: org_study_id